Oestrogen plus progestogen increased risk of breast cancer in postmenopausal women.
نویسنده
چکیده
and commentary also appear in ACP Journal Club. 172 Volume 8 November/December 2003 EBM Therapeutics www.evidence-basedmedicine.com group.bmj.com on June 22, 2017 Published by http://ebm.bmj.com/ Downloaded from
منابع مشابه
Postmenopausal hormone therapy before and after breast cancer: clinical experiences.
Conventional oestrogen-based hormone therapy (HT) increases the incidence of breast pain and tenderness, mammographic density and the risk of breast cancer. Combined oestrogen plus progestogen therapy (EPT) increases the risk of breast cancer to a greater degree than oestrogen alone (ET). Attention must therefore be focused on identifying women at risk of breast cancer or on producing a HT that...
متن کاملRole of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society.
OBJECTIVE To create an evidence-based position statement regarding the role of progestogen in postmenopausal hormone therapy (estrogen plus a progestogen, or EPT) for the management of menopause-related symptoms. DESIGN NAMS followed the general principles established for evidence-based guidelines to create this document. Clinicians and researchers acknowledged to be experts in the field of p...
متن کاملOestrogen plus progestogen did not prevent cardiovascular disease in postmenopausal women.
Manson JE, Hsia J, Johnson KC, et al, for the Women’s Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523–34. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...
متن کاملHealth consequences of short- and long-term postmenopausal hormone therapy.
Some women take an estrogen preparation for as long as several years to ease symptoms of the menopause. Such women appear to have little or no alteration in their risk of endometrial cancer, especially if they are also taking a progestogen, and no alteration in their risk of breast cancer. Similarly, the incidence of fractures is unaffected by relatively short-term hormone use. The risk of isch...
متن کاملThe laboratory diagnosis of common genital viral infections.
Journal of Family Planning and Reproductive Health Care 2004: 30(1) 11 Mosca L, Collins P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 499–503. 12 Shumaker SA, Legault C, Rapp SR, et al Estrogen plus progestin and the incidence of dementia and mild cognitive imp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Evidence-based nursing
دوره 7 1 شماره
صفحات -
تاریخ انتشار 2004